Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA 94118, USA.
Transfusion. 2012 May;52(5):936-45. doi: 10.1111/j.1537-2995.2011.03366.x. Epub 2011 Oct 7.
Transfusion-associated microchimerism (TA-MC), the persistence of significant levels of donor white blood cells (WBCs) in blood recipients for prolonged periods, has been demonstrated after nonleukoreduced and leukoreduced transfusion to patients with severe traumatic injury. Development of TA-MC has not been rigorously studied in settings that do not involve massive trauma where the blood is leukoreduced and irradiated.
A cohort of 409 prospectively followed medical and surgical adult and pediatric female recipients of leukoreduced and mostly irradiated allogeneic red blood cell and platelet transfusions were evaluated to determine development of TA-MC. Four- and 8-weeks-posttransfusion samples were analyzed using quantitative real-time polymerase chain reaction for Y-chromosome sequences in WBC DNA, the marker for microchimeric cells in female blood recipients. Repeat testing was performed on Y-chromosome-positive samples to confirm microchimerism (MC), and subsequent posttransfusion samples were tested to investigate persistence of MC.
On initial testing, 40 of 207 (19%) adult and 44 of 202 (22%) pediatric female blood recipients demonstrated low-level MC. On repeat testing of these and additional specimens, 12 (3%) recipients demonstrated low-level transient MC, but none had persistent TA-MC similar to that seen in transfused trauma patients.
Persistence of MC was not demonstrated in adult and pediatric recipients of leukoreduced and mostly irradiated blood components. The risk of TA-MC appears to be dependent on the clinical setting and is rare other than in patients sustaining severe traumatic injury.
输注相关的微嵌合体(TA-MC)是指供体白细胞(WBC)在血液受者中长时间持续存在显著水平,在非白细胞减少和白细胞减少输血给严重创伤患者后已经得到证实。在不涉及大量创伤的情况下,白细胞减少和照射的血液输注中,尚未严格研究 TA-MC 的发展情况。
评估了一组 409 名前瞻性随访的接受白细胞减少和大部分照射的同种异体红细胞和血小板输注的成年和儿科女性医疗和外科受者,以确定 TA-MC 的发展情况。在输注后 4 周和 8 周时,使用实时定量聚合酶链反应分析 WBC DNA 中的 Y 染色体序列,这是女性血液受者中微嵌合体细胞的标志物。对 Y 染色体阳性样本进行重复测试以确认微嵌合(MC),并随后测试后续输血样本以研究 MC 的持续性。
在初始测试中,207 名成年女性和 202 名儿科女性中的 40 名(19%)和 44 名(22%)显示低水平 MC。对这些和其他样本的重复测试中,12 名(3%)受者显示低水平一过性 MC,但没有受者表现出类似于输血创伤患者的持续 TA-MC。
在接受白细胞减少和大部分照射的血液成分的成年和儿科受者中,未显示 MC 的持续性。TA-MC 的风险似乎取决于临床情况,除了严重创伤患者外,很少见。